4.7 Article

Influence of alcohol on newly developed metabolic dysfunction-associated fatty liver disease in both sexes: A longitudinal study

Related references

Note: Only part of the references are listed.
Review Gastroenterology & Hepatology

Redefinition of Fatty Liver Disease from NAFLD to MAFLD through the Lens of Drug Development and Regulatory Science

Yasser Fouad et al.

Summary: Metabolic (dysfunction)-associated fatty liver disease (MAFLD) affects a significant portion of the population and is a leading cause of liver-related mortality. The outdated terminology and definitions of the disease are hindering the development of new drugs and treatments. An international consensus panel has proposed renaming the disease from nonalcoholic fatty liver disease (NAFLD) to MAFLD, along with new diagnostic criteria. Collaborating with various stakeholders in MAFLD care, there is a shared sense of urgency to implement these changes and work towards more efficient care and innovative solutions. Despite challenges in clinical inertia and recent trends, the MAFLD initiative provides a foundation for progress towards better care and outcomes for patients with this significant public health burden.

JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2022)

Letter Gastroenterology & Hepatology

Global multi-stakeholder endorsement of the MAFLD definition

Nahum Mendez-Sanchez et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Impact of the New Definition of Metabolic Associated Fatty Liver Disease on the Epidemiology of the Disease

Vincent Wai-Sun Wong et al.

Summary: The new definition of MAFLD does not significantly change the prevalence compared with NAFLD, but it may reduce the incidence by 25%. People with hepatic steatosis but not fulfilling the definition of MAFLD unlikely have significant liver disease.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retrospective nationwide claims database study in Japan

Masato Yoneda et al.

Summary: The study found that the incidence rate of CVD increased significantly in NAFLD or MAFLD patients, and the proportion of diabetes mellitus and hypertriglyceridemia among them is also high, which may affect the development of CVD.

JOURNAL OF GASTROENTEROLOGY (2021)

Review Gastroenterology & Hepatology

The Latin American Association for the Study of the Liver (ALEH) position statement on the redefinition of fatty liver disease

Nahum Mendez-Sanchez et al.

Summary: The Latin American Association for the Study of the Liver aims to promote liver health and quality patient care, with a recent focus on fatty liver disease associated with metabolic dysfunction. A consensus was reached to rename the disease as metabolic-associated fatty liver disease and to diagnose it using a set of simple criteria. This change is expected to improve disease awareness and advancements in various aspects of the disease.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Prevention of NAFLD-associated HCC: Role of lifestyle and chemoprevention

Naomi F. Lange et al.

Summary: This review highlights the increasing burden of hepatocellular carcinoma associated with nonalcoholic fatty liver disease and non-alcoholic steatohepatitis worldwide. Preventive strategies including lifestyle factors and chemopreventive treatments are crucial in combating this trend. The role of adjuvant therapies for tertiary prevention of HCC is briefly reviewed.

JOURNAL OF HEPATOLOGY (2021)

Review Gastroenterology & Hepatology

Diet and exercise in NAFLD/NASH: Beyond the obvious

Georg Semmler et al.

Summary: Lifestyle plays a crucial role in the development of NAFLD, with this review emphasizing the importance of calorie restriction and the potential impact of ketogenic diets in targeting NAFLD. Personalized dietary and exercise strategies are necessary, with further research needed on the interactions between diet, exercise, gut microbiota, and individual genetic background.

LIVER INTERNATIONAL (2021)

Article Medicine, General & Internal

NAFLD or MAFLD: Which Has Closer Association With All-Cause and Cause-Specific Mortality?-Results From NHANES III

Qi Huang et al.

Summary: The study found that participants with MAFLD or NAFLD were highly concordant, with MAFLD showing a greater overall mortality risk compared to NAFLD, but equal risk for cause-specific mortality. The new terminology excluded participants with lower mortality risk and included those with higher risk.

FRONTIERS IN MEDICINE (2021)

Article Gastroenterology & Hepatology

Alcohol Use Is Associated With Hepatic Steatosis Among Persons With Presumed Nonalcoholic Fatty Liver Disease

Michelle T. Long et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)

Editorial Material Gastroenterology & Hepatology

Redefining non-alcoholic fatty liver disease: what's in a name?

[Anonymous]

LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)

Editorial Material Gastroenterology & Hepatology

From NAFLD to MAFLD: when pathophysiology succeeds

Herbert Tilg et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Article Medicine, General & Internal

Sex and gender: modifiers of health, disease, and medicine

Franck Mauvais-Jarvis et al.

LANCET (2020)

Article Gastroenterology & Hepatology

MAFLD identifies patients with significant hepatic fibrosis better than NAFLD

Sakura Yamamura et al.

LIVER INTERNATIONAL (2020)

Review Gastroenterology & Hepatology

Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease

Laurent Castera et al.

GASTROENTEROLOGY (2019)

Review Gastroenterology & Hepatology

Clinical relevance of liver histopathology and different histological classifications of NASH in adults

Fabio Nascimbeni et al.

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2018)

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines: Management of alcohol-related liver disease

Mark Thursz et al.

JOURNAL OF HEPATOLOGY (2018)

Review Gastroenterology & Hepatology

Noninvasive biomarkers in NAFLD and NASH - current progress and future promise

Vincent Wai-Sun Wong et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)

Review Gastroenterology & Hepatology

Is Moderate Alcohol Use in Nonalcoholic Fatty Liver Disease Good or Bad? A Critical Review

Veeral H. Ajmera et al.

HEPATOLOGY (2017)

Article Multidisciplinary Sciences

Sexual Dimorphism in Alcohol Induced Adipose Inflammation Relates to Liver Injury

Melissa A. Fulham et al.

PLOS ONE (2016)

Article Substance Abuse

Ethnic Differences in Presentation and Severity of Alcoholic Liver Disease

Robert E. Levy et al.

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2015)

Article Genetics & Heredity

Variant in PNPLA3 is associated with alcoholic liver disease

Chao Tian et al.

NATURE GENETICS (2010)

Review Substance Abuse

Alcohol as a risk factor for liver cirrhosis: A systematic review and meta-analysis

Juergen Rehm et al.

DRUG AND ALCOHOL REVIEW (2010)

Article Gastroenterology & Hepatology

Light and Moderate Alcohol Consumption Significantly Reduces the Prevalence of Fatty Liver in the Japanese Male Population

Toshiaki Gunji et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)

Article Gastroenterology & Hepatology

Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease

Winston Dunn et al.

HEPATOLOGY (2008)

Article Gastroenterology & Hepatology

Light to moderate alcohol consumption is associated with lower frequency of hypertransaminasemia

Ayako Suzuki et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)

Article Gastroenterology & Hepatology

Joint effects of body weight and alcohol on elevated serum alanine aminotransferase in the United States population

CE Ruhl et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2005)

Review Gastroenterology & Hepatology

Recent advances in alcoholic liver disease - II. Minireview: molecular mechanisms of alcoholic fatty liver

M You et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2004)

Article Gastroenterology & Hepatology

The utility of radiological imaging in nonalcoholic fatty liver disease

S Saadeh et al.

GASTROENTEROLOGY (2002)

Article Gastroenterology & Hepatology

The antiestrogen toremifene protects against alcoholic liver injury in female rats

HA Järveläinen et al.

JOURNAL OF HEPATOLOGY (2001)